Decoding the Complexity of Systemic Inflammation Predictors in Locally Advanced Cervical Cancer, with Hemoglobin as the Hidden Key (the ESTHER Study).

Abstract

Locally advanced cervical cancer (LACC) is treated with concurrent chemoradiation (CRT). Predictive models could improve the outcome through treatment personalization. Several factors influence prognosis in LACC, but the role of systemic inflammation indices (IIs) is unclear. This study aims to assess the correlation between IIs and prognosis in a large patient cohort considering several clinical data. We retrospectively analyzed pretreatment IIs (NLR, PLR, MLR, SII, LLR, COP-NLR, APRI, ALRI, SIRI, and ANRI) in 173 LACC patients. Patient, tumor, and treatment characteristics were also considered. Univariate and multivariate Cox's regressions were conducted to assess associations between IIs and clinical factors with local control (LC), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS). Univariate analysis showed significant correlations between age, HB levels, tumor stage, FIGO stage, and CRT dose with survival outcomes. Specific pretreatment IIs (NLR, PLR, APRI, ANRI, and COP-NLR) demonstrated associations only with LC. The multivariate analysis confirmed Hb levels, CRT dose, and age as significant predictors of OS, while no II was correlated with any clinical outcome. The study findings contradict some prior research on IIs in LACC, emphasizing the need for comprehensive assessments of potential confounding variables.

• Authors: Federica Medici, Martina Ferioli, Ludovica Forlani, Viola Laghi, Johnny Ma, Savino Cilla, Milly Buwenge, Gabriella Macchia, Francesco Deodato, Maria Vadalà, Claudio Malizia, Luca Tagliaferri, Anna Myriam Perrone, Pierandrea De Iaco, Lidia Strigari, Alessandra Arcelli, Alessio Giuseppe Morganti
• Journal: Cancers (Cancers (Basel)) Vol. 15 Issue 20 (Oct 19 2023) ISSN: 2072-6694 [Print] Switzerland
• PMID: 37894423 (Publication Type: Journal Article)